Similar Medicine Of Oxalgin Nano Gel 50gm
Discover the Benefits of ABHA Card registration
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHAIntroduction to Oxalgin Nano Gel 50gm
How Oxalgin Nano Gel 50gm works
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that helps reduce inflammation and pain by inhibiting certain substances in the body. Methyl salicylate acts as a counterirritant, providing a warming sensation that helps distract from deeper aches. Menthol offers a cooling effect that soothes the affected area and enhances blood flow, contributing to pain relief.
How To Use Oxalgin Nano Gel 50gm
- Gently apply a small amount of gel to the affected area.
- Massage the gel into the skin until fully absorbed.
- Use 3 to 4 times daily for optimal results.
Special Precautions About Oxalgin Nano Gel 50gm
- Avoid contact with eyes and mucous membranes.
- Do not apply to broken or irritated skin.
- Consult a doctor if pregnant or breastfeeding.
- Keep out of reach of children.
- Store in a cool, dry place below 25°C.
Benefits Of Oxalgin Nano Gel 50gm
- Provides quick relief from pain and inflammation.
- Reduces swelling in affected areas.
- Offers a soothing cooling and warming sensation.
- Improves blood circulation to the affected area.
Side Effects Of Oxalgin Nano Gel 50gm
- Common side effects may include mild skin irritation or redness.
- Serious side effects are rare but can include severe allergic reactions such as rash, itching, or swelling. Discontinue use and seek medical attention if these occur.
Health And Lifestyle
Disease Explanation

Pain and inflammation are common responses of the body to injury, infection, or irritation. Pain is the body's way of signaling that something is wrong, while inflammation is the immune system’s reaction, causing redness, swelling, heat, and discomfort in the affected area. These symptoms can occur in conditions like arthritis, injuries, or infections.
Written By
Priyanka Sonkushre
Content Updated on
Wednesday, 18 June, 2025